SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-13-004850
Filing Date
2013-04-25
Accepted
2013-04-25 13:44:49
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2214525z10-q.htm 10-Q 330960
2 EX-31.1 a2214525zex-31_1.htm EX-31.1 14755
3 EX-32.1 a2214525zex-32_1.htm EX-32.1 7508
10 G384178.JPG g384178.jpg GRAPHIC 10449
  Complete submission text file 0001047469-13-004850.txt   3378132

Data Files

Seq Description Document Type Size
4 EX-101.INS nutr-20130331.xml EX-101.INS 275982
5 EX-101.SCH nutr-20130331.xsd EX-101.SCH 44512
6 EX-101.CAL nutr-20130331_cal.xml EX-101.CAL 55619
7 EX-101.DEF nutr-20130331_def.xml EX-101.DEF 138929
8 EX-101.LAB nutr-20130331_lab.xml EX-101.LAB 784839
9 EX-101.PRE nutr-20130331_pre.xml EX-101.PRE 369041
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Filer) CIK: 0001050007 (see all company filings)

IRS No.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-23731 | Film No.: 13782168
SIC: 2833 Medicinal Chemicals & Botanical Products